Christelle Gedeon Sells 58,994 Shares of Canopy Growth (NASDAQ:CGC) Stock

Canopy Growth Corporation (NASDAQ:CGC) insider Christelle Gedeon sold 58,994 shares of the stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of $0.97, for a total transaction of $57,224.18. Following the sale, the insider directly owned 705,506 shares of the company’s stock, valued at approximately $684,340.82. This represents a 7.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Canopy Growth Trading Down 1.1%

Canopy Growth stock opened at $0.95 on Wednesday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 2.64 and a current ratio of 3.34. The firm has a market cap of $382.38 million, a price-to-earnings ratio of -1.60 and a beta of 0.77. Canopy Growth Corporation has a 1 year low of $0.84 and a 1 year high of $2.38. The firm’s 50 day moving average price is $1.07 and its two-hundred day moving average price is $1.12.

Canopy Growth (NASDAQ:CGC) last released its quarterly earnings data on Monday, June 15th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.11). Canopy Growth had a negative return on equity of 26.95% and a negative net margin of 75.27%.The company had revenue of $51.22 million for the quarter, compared to the consensus estimate of $53.43 million. On average, research analysts predict that Canopy Growth Corporation will post -0.11 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CGC. Jones Financial Companies Lllp increased its stake in Canopy Growth by 10,308.3% in the 1st quarter. Jones Financial Companies Lllp now owns 969,533 shares of the company’s stock valued at $882,000 after buying an additional 960,218 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Canopy Growth by 64.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 330,278 shares of the company’s stock valued at $301,000 after buying an additional 129,620 shares during the period. Murchinson Ltd. purchased a new position in shares of Canopy Growth during the 2nd quarter valued at $183,000. Boothbay Fund Management LLC purchased a new position in shares of Canopy Growth during the 2nd quarter valued at $30,000. Finally, Tidal Investments LLC increased its stake in shares of Canopy Growth by 31.5% in the second quarter. Tidal Investments LLC now owns 5,033,793 shares of the company’s stock worth $6,141,000 after acquiring an additional 1,204,530 shares during the last quarter. 3.33% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Canopy Growth

Here are the key news stories impacting Canopy Growth this week:

• Positive Sentiment: Broader commentary on Canadian cannabis stocks suggests the sector is still showing momentum in 2026, with some companies improving profitability and expanding internationally as legalization efforts progress. Leading Canadian Marijuana Stocks Showing Momentum in 2026
• Neutral Sentiment: Analysts currently have an average “Hold” rating on Canopy Growth, which signals limited conviction but not an outright bearish consensus. Canopy Growth Corporation (NASDAQ:CGC) Given Average Recommendation of “Hold” by Brokerages
• Neutral Sentiment: Institutional investors have been active in CGC, with some funds adding shares even as the stock remains deeply discounted and volatile. That can provide some support, but it does not offset the company’s operating challenges. Constellation Brands: A Fallen Star or a Hidden Value Play?
• Negative Sentiment: Canopy Growth CEO Luc Mongeau sold 135,231 shares, while insider Christelle Gedeon sold 58,994 shares and Thomas Carlton Stewart sold 9,285 shares. Multiple insider sales can weigh on sentiment because they may suggest management sees limited near-term upside. Canopy Growth (NASDAQ:CGC) CEO Luc Mongeau Sells 135,231 Shares
• Negative Sentiment: The stock also fell after the company’s recent earnings report, where Canopy Growth missed analyst estimates on both EPS and revenue, reinforcing concerns about profitability and growth. Canopy Growth Corporation (CGC) Dips More Than Broader Market: What You Should Know

Analyst Ratings Changes

Several research firms have recently weighed in on CGC. Canaccord Genuity Group started coverage on shares of Canopy Growth in a research report on Friday, March 27th. They issued a “buy” rating on the stock. Weiss Ratings lowered shares of Canopy Growth from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, June 15th. ATB Cormark Capital Markets upgraded shares of Canopy Growth from a “strong sell” rating to a “moderate buy” rating in a research report on Tuesday, March 17th. Finally, Wall Street Zen downgraded shares of Canopy Growth from a “hold” rating to a “sell” rating in a research note on Sunday, March 29th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold”.

About Canopy Growth

Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets.

The company operates through multiple subsidiaries, including Tweed Inc, Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments.